Creo Medical Group (CREO)

Sector:

Health Care

Index:

FTSE AIM All-Share

 39.50p
   
  • Change Today:
      0.000p
  • 52 Week High: 172.00p
  • 52 Week Low: 39.00p
  • Currency: UK Pounds
  • Shares Issued: 181.55m
  • Volume: 76,828
  • Market Cap: 71.71m

Financial Analysis

Select chart: EPS | Dividend | Revenue

Latest Interim/Quarterly

Period Ending Period Revenue (m) Pre-tax (m) EPS Dividend
30-Jun-22 Interim 13.64 (16.00) (7.00)p n/a

Key Fundamentals

Year Ending Revenue (m) Pre-tax (m) EPS P/E PEG EPS Grth. Div Yield
30-Jun-17 n/a (8.91) (7.30)p n/a n/a n/a n/a 0.0%
31-Dec-18 n/a (17.58) (15.98)p n/a n/a n/a n/a 0.0%
31-Dec-19 0.01 (18.62) (12.99)p n/a n/a n/a n/a 0.0%
31-Dec-20 9.43 (23.46) (12.99)p n/a n/a n/a n/a 0.0%
31-Dec-21 25.16 (30.34) (15.00)p n/a n/a n/a n/a 0.0%

a. Based on UK GAAP presentation of accounts - includes discontinued activities

Forecasts

Year Ending Revenue (m) Pre-tax (m) EPS P/E PEG EPS Grth. Div Yield
31-Dec-22 27.91 (29.19) (13.27)p n/a n/a n/a n/a 0.0%
31-Dec-23 32.06 (27.49) (12.43)p n/a n/a n/a n/a 0.0%

Copyright © 2022 FactSet Research Systems Inc. All rights reserved.

Price / Earnings Data

5 Yr High 5 Yr Low 5 Yr Avg Curr / Avg
Latest n/a n/a n/a 0

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: Above ratios are on a 'per annum' basis, adjusted for corporate actions and based on the fundamentals of the primary listed security.

Note 3: Under IFRS, all figures are based on 'Continuing' operations unless otherwise stated.

Note 4: In the case of dual listed securities, broker recommendations and forecasts relate to the primary listing.

Note 5: Forecast figures based on normalised accounts.

 

IFRS Changes - Find Out More

Find out about IFRS and how this affects the financial infomation for all UK companies.

CREO Market Data

Currency UK Pounds
Share Price 39.50p
Change Today 0.000p
% Change 0.00 %
52 Week High 172.00p
52 Week Low 39.00p
Volume 76,828
Shares Issued 181.55m
Market Cap 71.71m

CREO Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
34.03% above the market average34.03% above the market average34.03% above the market average34.03% above the market average34.03% above the market average
40.54% above the sector average40.54% above the sector average40.54% above the sector average40.54% above the sector average40.54% above the sector average
Price Trend
93.72% below the market average93.72% below the market average93.72% below the market average93.72% below the market average93.72% below the market average
89.74% below the sector average89.74% below the sector average89.74% below the sector average89.74% below the sector average89.74% below the sector average
Income Not Available
Growth
47.67% above the market average47.67% above the market average47.67% above the market average47.67% above the market average47.67% above the market average
66.67% above the sector average66.67% above the sector average66.67% above the sector average66.67% above the sector average66.67% above the sector average

What The Brokers Say

Strong Buy 2
Buy 0
Neutral 0
Sell 0
Strong Sell 0
Total 2
strong_buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

CREO Dividends

No dividends found

Trades for 25-Nov-2022

Time Volume / Share Price
16:35 25 @ 40.00p
16:35 6 @ 40.00p
16:35 2 @ 40.00p
16:35 37 @ 40.00p
16:35 10 @ 40.00p

CREO Key Personnel

CEO Craig Jonathan Gulliford
CFO Richard John Rees

Top of Page